tiprankstipranks
Trending News
More News >
Unity Biotechnology (UNBX)
OTHER OTC:UNBX
US Market
Advertisement

Unity Biotechnology (UNBX) Stock Forecast & Price Target

Compare
789 Followers
See the Price Targets and Ratings of:

UNBX Financial Forecast

UNBX Earnings Forecast

Next quarter’s earnings estimate for UNBX is -$0.17 with a range of -$0.17 to -$0.17. The previous quarter’s EPS was -$0.43. UNBX beat its EPS estimate 33.33% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.05% of the time in the same period. In the last calendar year UNBX has Outperformed its overall industry.
Next quarter’s earnings estimate for UNBX is -$0.17 with a range of -$0.17 to -$0.17. The previous quarter’s EPS was -$0.43. UNBX beat its EPS estimate 33.33% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.05% of the time in the same period. In the last calendar year UNBX has Outperformed its overall industry.

UNBX Sales Forecast

Next quarter’s sales forecast for UNBX is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. UNBX beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 46.90% of the time in the same period. In the last calendar year UNBX has Preformed in-line its overall industry.
Next quarter’s sales forecast for UNBX is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. UNBX beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 46.90% of the time in the same period. In the last calendar year UNBX has Preformed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Mizuho Securities Analyst forecast on UNBX
Mizuho Securities
Mizuho Securities
$6$1
Hold
1011.11%
Upside
Downgraded
05/19/25
Unity Biotechnology (UBX) was downgraded to a Hold Rating at Mizuho Securities
TR | OpenAI - 4o Analyst forecast on UNBX
TR | OpenAI - 4o
TR | OpenAI - 4o
Sell
Reiterated
04/25/25
AI Generated ArticleAI Generated Article
Chardan Capital Analyst forecast on UNBX
Chardan Capital
Chardan Capital
$6$4
Buy
4344.44%
Upside
Reiterated
03/25/25
Unity Biotechnology price target lowered to $4 from $6 at ChardanUnity Biotechnology price target lowered to $4 from $6 at Chardan
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Mizuho Securities Analyst forecast on UNBX
Mizuho Securities
Mizuho Securities
$6$1
Hold
1011.11%
Upside
Downgraded
05/19/25
Unity Biotechnology (UBX) was downgraded to a Hold Rating at Mizuho Securities
TR | OpenAI - 4o Analyst forecast on UNBX
TR | OpenAI - 4o
TR | OpenAI - 4o
Sell
Reiterated
04/25/25
AI Generated ArticleAI Generated Article
Chardan Capital Analyst forecast on UNBX
Chardan Capital
Chardan Capital
$6$4
Buy
4344.44%
Upside
Reiterated
03/25/25
Unity Biotechnology price target lowered to $4 from $6 at ChardanUnity Biotechnology price target lowered to $4 from $6 at Chardan
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Unity Biotechnology

1 Month
xxx
Success Rate
1/2 ratings generated profit
50%
Average Return
-4.55%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of -4.55% per trade.
3 Months
xxx
Success Rate
0/2 ratings generated profit
0%
Average Return
-42.05%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -42.05% per trade.
1 Year
Daniil GataulinChardan Capital
Success Rate
0/2 ratings generated profit
0%
Average Return
-94.55%
reiterated a buy rating 5 months ago
Copying Daniil Gataulin's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -94.55% per trade.
2 Years
xxx
Success Rate
0/2 ratings generated profit
0%
Average Return
-94.55%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -94.55% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

UNBX Analyst Recommendation Trends

Rating
Feb 25
Mar 25
Apr 25
May 25
Jul 25
Strong Buy
2
5
5
4
1
Buy
0
1
1
1
0
Hold
6
5
0
2
3
Sell
0
2
4
4
2
Strong Sell
0
0
0
0
0
total
8
13
10
11
6
In the current month, UNBX has received 1 Buy Ratings, 3 Hold Ratings, and 2 Sell Ratings. UNBX average Analyst price target in the past 3 months is 1.00.
Each month's total comprises the sum of three months' worth of ratings.

UNBX Stock Forecast FAQ

What is UNBX’s average 12-month price target, according to analysts?
Based on analyst ratings, Unity Biotechnology’s 12-month average price target is 1.00.
    What is UNBX’s upside potential, based on the analysts’ average price target?
    Unity Biotechnology has 1011.11% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is UNBX a Buy, Sell or Hold?
          Unity Biotechnology has a consensus rating of Hold which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Unity Biotechnology’s price target?
            The average price target for Unity Biotechnology is 1.00. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $1.00 ,the lowest forecast is $1.00. The average price target represents 1011.11% Increase from the current price of <$0.1.
              What do analysts say about Unity Biotechnology?
              Unity Biotechnology’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
                How can I buy shares of UNBX?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis